6681 — BrainAurora Medical Technology Income Statement
0.000.00%
Last trade - 00:00- HK$4.94bn
- HK$5.09bn
- CNY220.05m
Annual income statement for BrainAurora Medical Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2.3 | 11.3 | 67.2 | 122 | 220 |
| Cost of Revenue | |||||
| Gross Profit | 1.3 | 3.3 | 32.1 | 54 | 89.5 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 694 | 495 | 406 | 299 | 512 |
| Operating Profit | -691 | -483 | -339 | -177 | -292 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -698 | -502 | -359 | -199 | -316 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -698 | -502 | -359 | -199 | -316 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -698 | -502 | -359 | -198 | -315 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -698 | -502 | -359 | -198 | -315 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.551 | -0.397 | -0.263 | -0.145 | -0.245 |